4-76739009-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020859.4(SHROOM3):​c.836G>C​(p.Gly279Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.736 in 1,613,912 control chromosomes in the GnomAD database, including 440,353 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 38116 hom., cov: 33)
Exomes 𝑓: 0.74 ( 402237 hom. )

Consequence

SHROOM3
NM_020859.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.849

Publications

36 publications found
Variant links:
Genes affected
SHROOM3 (HGNC:30422): (shroom family member 3) This gene encodes a PDZ-domain-containing protein that belongs to a family of Shroom-related proteins. This protein may be involved in regulating cell shape in certain tissues. A similar protein in mice is required for proper neurulation. [provided by RefSeq, Jan 2011]
SHROOM3-AS1 (HGNC:41265): (SHROOM3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.4019361E-6).
BP6
Variant 4-76739009-G-C is Benign according to our data. Variant chr4-76739009-G-C is described in ClinVar as Benign. ClinVar VariationId is 403437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SHROOM3NM_020859.4 linkc.836G>C p.Gly279Ala missense_variant Exon 5 of 11 ENST00000296043.7 NP_065910.3
SHROOM3-AS1NR_187404.1 linkn.1044+3799C>G intron_variant Intron 3 of 3
SHROOM3-AS1NR_187405.1 linkn.500+3799C>G intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SHROOM3ENST00000296043.7 linkc.836G>C p.Gly279Ala missense_variant Exon 5 of 11 1 NM_020859.4 ENSP00000296043.6

Frequencies

GnomAD3 genomes
AF:
0.705
AC:
107154
AN:
152010
Hom.:
38078
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.630
Gnomad AMI
AF:
0.873
Gnomad AMR
AF:
0.722
Gnomad ASJ
AF:
0.747
Gnomad EAS
AF:
0.578
Gnomad SAS
AF:
0.724
Gnomad FIN
AF:
0.707
Gnomad MID
AF:
0.756
Gnomad NFE
AF:
0.750
Gnomad OTH
AF:
0.706
GnomAD2 exomes
AF:
0.718
AC:
180327
AN:
251200
AF XY:
0.722
show subpopulations
Gnomad AFR exome
AF:
0.628
Gnomad AMR exome
AF:
0.710
Gnomad ASJ exome
AF:
0.751
Gnomad EAS exome
AF:
0.589
Gnomad FIN exome
AF:
0.700
Gnomad NFE exome
AF:
0.750
Gnomad OTH exome
AF:
0.720
GnomAD4 exome
AF:
0.740
AC:
1081391
AN:
1461784
Hom.:
402237
Cov.:
79
AF XY:
0.740
AC XY:
538349
AN XY:
727178
show subpopulations
African (AFR)
AF:
0.626
AC:
20947
AN:
33480
American (AMR)
AF:
0.710
AC:
31751
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.749
AC:
19573
AN:
26136
East Asian (EAS)
AF:
0.512
AC:
20341
AN:
39694
South Asian (SAS)
AF:
0.733
AC:
63200
AN:
86252
European-Finnish (FIN)
AF:
0.698
AC:
37262
AN:
53412
Middle Eastern (MID)
AF:
0.675
AC:
3895
AN:
5768
European-Non Finnish (NFE)
AF:
0.756
AC:
840338
AN:
1111948
Other (OTH)
AF:
0.730
AC:
44084
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
19349
38698
58046
77395
96744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20322
40644
60966
81288
101610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.705
AC:
107255
AN:
152128
Hom.:
38116
Cov.:
33
AF XY:
0.701
AC XY:
52158
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.631
AC:
26185
AN:
41498
American (AMR)
AF:
0.722
AC:
11044
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.747
AC:
2592
AN:
3470
East Asian (EAS)
AF:
0.578
AC:
2978
AN:
5156
South Asian (SAS)
AF:
0.724
AC:
3490
AN:
4822
European-Finnish (FIN)
AF:
0.707
AC:
7479
AN:
10582
Middle Eastern (MID)
AF:
0.765
AC:
225
AN:
294
European-Non Finnish (NFE)
AF:
0.750
AC:
50972
AN:
67988
Other (OTH)
AF:
0.707
AC:
1494
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1594
3188
4783
6377
7971
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.742
Hom.:
31579
Bravo
AF:
0.706
TwinsUK
AF:
0.755
AC:
2799
ALSPAC
AF:
0.754
AC:
2905
ESP6500AA
AF:
0.629
AC:
2771
ESP6500EA
AF:
0.751
AC:
6462
ExAC
AF:
0.716
AC:
86891
Asia WGS
AF:
0.677
AC:
2353
AN:
3478
EpiCase
AF:
0.761
EpiControl
AF:
0.751

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

SHROOM3-related disorder Benign:1
Mar 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.53
DANN
Benign
0.10
DEOGEN2
Benign
0.036
T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.47
T;T
MetaRNN
Benign
0.0000014
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.1
L;.
PhyloP100
0.85
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.81
N;.
REVEL
Benign
0.18
Sift
Benign
0.70
T;.
Sift4G
Benign
1.0
T;.
Vest4
0.010
ClinPred
0.010
T
GERP RS
-0.95
Varity_R
0.029
gMVP
0.076
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs344140; hg19: chr4-77660162; COSMIC: COSV56024450; COSMIC: COSV56024450; API